← Open Payments lookup

JOHN WELBORN: Open Payments

NPI 1427496835 · GOUVERNEUR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,056 in 36 payments from 8 companies in 2025. Trend: 2023 $533 · 2024 $642 · 2025 $1,056

Food & beverage: $1,056
CompanyPaymentsAmount
Braeburn Inc.8$324
Indivior Inc.17$201
Madrigal Pharmaceuticals1$150
AstraZeneca Pharmaceuticals LP1$125
Otsuka America Pharmaceutical, Inc.4$112
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$98
Janssen Pharmaceuticals, Inc1$26
E.R. Squibb & Sons, L.L.C.1$20

Products named: BRIXADI, SUBLOCADE, REZDIFFRA, CAPLYTA, ABILIFY ASIMTUFII, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA.

Industry payments across NY — which companies pay providers there.